Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor

Neurosci Lett. 2022 Jan 19:769:136428. doi: 10.1016/j.neulet.2021.136428. Epub 2021 Dec 28.

Abstract

Parkinson's disease (PD) and essential tremor (ET) are two common adult-onset tremor disorders in which prevalence increases with age. PD is a neurodegenerative condition with progressive disability. In ET, neurodegeneration is not an established etiology. We sought to determine whether an underlying metabolic pattern may differentiate ET from PD. Circulating metabolites in plasma and cerebrospinal fluid (CSF) were analyzed using gas chromatography-mass spectroscopy. There were several disrupted pathways in PD compared to ET plasma including glycolysis, tyrosine, phenylalanine, tyrosine biosynthesis, purine and glutathione metabolism. Elevated α-synuclein levels in plasma and CSF distinguished PD from ET. The perturbed metabolic state in PD was associated with imbalance in the pentose phosphate pathway, deficits in energy production, and change in NADPH, NADH and nicotinamide phosphoribosyltransferase levels. This work demonstrates significant metabolic differences in plasma and CSF of PD and ET patients.

Keywords: Alpha-synuclein; Cerebrospinal fluid; Metabolomic analysis; Parkinson’s disease; Plasma.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Biomarkers / blood
  • Biomarkers / cerebrospinal fluid
  • Diagnosis, Differential
  • Essential Tremor / blood*
  • Essential Tremor / cerebrospinal fluid
  • Essential Tremor / diagnosis
  • Female
  • Humans
  • Male
  • Middle Aged
  • NAD / blood
  • Nicotinamide Phosphoribosyltransferase / blood
  • Parkinson Disease / blood*
  • Parkinson Disease / cerebrospinal fluid
  • Parkinson Disease / diagnosis
  • Pentose Phosphate Pathway
  • alpha-Synuclein / blood*
  • alpha-Synuclein / cerebrospinal fluid

Substances

  • Biomarkers
  • alpha-Synuclein
  • NAD
  • Nicotinamide Phosphoribosyltransferase